BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

886 related articles for article (PubMed ID: 30926487)

  • 1. Microbiome-metabolomic analysis of the impact of Zizyphus jujuba cv. Muzao polysaccharides consumption on colorectal cancer mice fecal microbiota and metabolites.
    Ji X; Hou C; Zhang X; Han L; Yin S; Peng Q; Wang M
    Int J Biol Macromol; 2019 Jun; 131():1067-1076. PubMed ID: 30926487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polysaccharides from Lachnum sp. Inhibited colitis-associated colon tumorigenesis in mice by modulating fecal microbiota and metabolites.
    Zong S; Ye H; Ye Z; He Y; Zhang X; Ye M
    Int Immunopharmacol; 2022 Jul; 108():108656. PubMed ID: 35390743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer.
    Yang Y; Misra BB; Liang L; Bi D; Weng W; Wu W; Cai S; Qin H; Goel A; Li X; Ma Y
    Theranostics; 2019; 9(14):4101-4114. PubMed ID: 31281534
    [No Abstract]   [Full Text] [Related]  

  • 4. Variations in gut microbiota and fecal metabolic phenotype associated with depression by 16S rRNA gene sequencing and LC/MS-based metabolomics.
    Yu M; Jia H; Zhou C; Yang Y; Zhao Y; Yang M; Zou Z
    J Pharm Biomed Anal; 2017 May; 138():231-239. PubMed ID: 28219800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polysaccharides isolated from Nostoc commune Vaucher inhibit colitis-associated colon tumorigenesis in mice and modulate gut microbiota.
    Guo M; Li Z
    Food Funct; 2019 Oct; 10(10):6873-6881. PubMed ID: 31584586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiome-Metabolomics Analysis of the Impacts of Long-Term Dietary Advanced-Glycation-End-Product Consumption on C57BL/6 Mouse Fecal Microbiota and Metabolites.
    Qu W; Nie C; Zhao J; Ou X; Zhang Y; Yang S; Bai X; Wang Y; Wang J; Li J
    J Agric Food Chem; 2018 Aug; 66(33):8864-8875. PubMed ID: 30037223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer Pathogenesis.
    Kim M; Vogtmann E; Ahlquist DA; Devens ME; Kisiel JB; Taylor WR; White BA; Hale VL; Sung J; Chia N; Sinha R; Chen J
    mBio; 2020 Feb; 11(1):. PubMed ID: 32071266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of Bifidobacterium bifidum CGMCC 15068 modulates gut microbiota and metabolome in azoxymethane (AOM)/dextran sulphate sodium (DSS)-induced colitis-associated colon cancer (CAC) in mice.
    Wang Q; Wang K; Wu W; Lv L; Bian X; Yang L; Wang Q; Li Y; Ye J; Fang D; Wu J; Jiang X; Xie J; Lu Y; Li L
    Appl Microbiol Biotechnol; 2020 Jul; 104(13):5915-5928. PubMed ID: 32367312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metagenomic analysis of gut microbiota modulatory effects of jujube (Ziziphus jujuba Mill.) polysaccharides in a colorectal cancer mouse model.
    Ji X; Hou C; Gao Y; Xue Y; Yan Y; Guo X
    Food Funct; 2020 Jan; 11(1):163-173. PubMed ID: 31830158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated study of metabolomics and gut metabolic activity from ulcerative colitis to colorectal cancer: The combined action of disordered gut microbiota and linoleic acid metabolic pathway might fuel cancer.
    Tang Q; Cang S; Jiao J; Rong W; Xu H; Bi K; Li Q; Liu R
    J Chromatogr A; 2020 Oct; 1629():461503. PubMed ID: 32858455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin Reduces Colorectal Tumor Development in Mice and Gut Microbes Reduce its Bioavailability and Chemopreventive Effects.
    Zhao R; Coker OO; Wu J; Zhou Y; Zhao L; Nakatsu G; Bian X; Wei H; Chan AWH; Sung JJY; Chan FKL; El-Omar E; Yu J
    Gastroenterology; 2020 Sep; 159(3):969-983.e4. PubMed ID: 32387495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gallic Acid Alleviates Gut Dysfunction and Boosts Immune and Antioxidant Activities in Puppies Under Environmental Stress Based on Microbiome-Metabolomics Analysis.
    Yang K; Deng X; Jian S; Zhang M; Wen C; Xin Z; Zhang L; Tong A; Ye S; Liao P; Xiao Z; He S; Zhang F; Deng J; Zhang L; Deng B
    Front Immunol; 2021; 12():813890. PubMed ID: 35095912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal and serum metabolomic signatures and gut microbiota characteristics of allergic rhinitis mice model.
    Chen Z; He S; Wei Y; Liu Y; Xu Q; Lin X; Chen C; Lin W; Wang Y; Li L; Xu Y
    Front Cell Infect Microbiol; 2023; 13():1150043. PubMed ID: 37180443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Holistic View of Berberine Inhibiting Intestinal Carcinogenesis in Conventional Mice Based on Microbiome-Metabolomics Analysis.
    Chen H; Zhang F; Zhang J; Zhang X; Guo Y; Yao Q
    Front Immunol; 2020; 11():588079. PubMed ID: 33072135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 17β-Estradiol supplementation changes gut microbiota diversity in intact and colorectal cancer-induced ICR male mice.
    Song CH; Kim N; Nam RH; Choi SI; Lee HN; Surh YJ
    Sci Rep; 2020 Jul; 10(1):12283. PubMed ID: 32704056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gavage of Fecal Samples From Patients With Colorectal Cancer Promotes Intestinal Carcinogenesis in Germ-Free and Conventional Mice.
    Wong SH; Zhao L; Zhang X; Nakatsu G; Han J; Xu W; Xiao X; Kwong TNY; Tsoi H; Wu WKK; Zeng B; Chan FKL; Sung JJY; Wei H; Yu J
    Gastroenterology; 2017 Dec; 153(6):1621-1633.e6. PubMed ID: 28823860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in the Gut Microbiome and Cecal Metabolome During
    Wu T; Xu F; Su C; Li H; Lv N; Liu Y; Gao Y; Lan Y; Li J
    Front Immunol; 2020; 11():1331. PubMed ID: 32849494
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro antioxidative and immunological activities of polysaccharides from Zizyphus Jujuba cv. Muzao.
    Zhang L; Liu X; Wang Y; Liu G; Zhang Z; Zhao Z; Cheng H
    Int J Biol Macromol; 2017 Feb; 95():1119-1125. PubMed ID: 27815124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer.
    Zhang SL; Mao YQ; Zhang ZY; Li ZM; Kong CY; Chen HL; Cai PR; Han B; Ye T; Wang LS
    Theranostics; 2021; 11(9):4155-4170. PubMed ID: 33754054
    [No Abstract]   [Full Text] [Related]  

  • 20. Structural shift of gut microbiota during chemo-preventive effects of epigallocatechin gallate on colorectal carcinogenesis in mice.
    Wang X; Ye T; Chen WJ; Lv Y; Hao Z; Chen J; Zhao JY; Wang HP; Cai YK
    World J Gastroenterol; 2017 Dec; 23(46):8128-8139. PubMed ID: 29290650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.